RecallDepth
Class II Ongoing

LOSARTAN POTASSIUM 100 mg TABLET BULK 90 count bottles, NDC 00591-3747-00

This recall is currently active, issued July 17, 2019. It was issued by Teva Pharmaceuticals Usa.

Company
Teva Pharmaceuticals Usa
Recall Initiated
June 6, 2019
Posted
July 17, 2019
Recall Number
D-1456-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2,943,000 tablets
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Distribution

Nationwide by 4 major distributors.

Lot / Code Info

Arrow Malta (Teva) Bulk Product Lot # 1163892A, exp. date 01/2020 1163893A, exp. date 01/2020 1163894A, exp. date 01/2020 1163895A, exp. date 01/2020 Golden State Medical Finished Product Lot # GS017042, exp. date 01/2020 GS017043, exp. date 01/2020 GS017044, exp. date 01/2020 GS017541, exp. date 01/2020

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls